Sign in
Taking people in United StatesEarly phase 1

Stellate ganglion block and its effects on the heart in ventricular tachycardia

Studies how a nerve block affects heart signals in people with ventricular tachycardia.

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia, United StatesSee the site
Trial code
Registry title
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
Status
Recruiting
Phase
Early phase 1
People taking part
20 people, planned
Started
1 Sept 2022
Expected to end
1 Jul 2027
Type of study
Interventional
Treatments tested
  • Stellate Ganglion Block
Record updated
21 November 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with ventricular tachycardia (a fast, abnormal heart rhythm) who are planned to have a catheter-based VT ablation. During the ablation, everyone gets a stellate ganglion block (a numbing injection into a nerve bundle in the neck).

Age
18 years and older
Sex
All sexes
Disease stage
Ventricular tachycardia (VT) with a planned catheter-based VT ablation

Main reasons for not taking part

  • Pregnancy
  • Medical reasons against a stellate ganglion block or VT ablation
  • Allergy to amide-type local anaesthetics (numbing drugs)
  • Unstable blood pressure or circulation during the procedure, before the study steps start

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Planned catheter based VT ablation
  • Age at least 18 years

Who cannot take part

  • Hemodynamic instability during the procedure prior to the study protocol
  • Hypersensitivity of local anesthetic of amide type
  • Pregnancy
  • Contraindication to SGB or VT ablation

Where in United States

  • Hospital of the University of PennsylvaniaPhiladelphia, United StatesContact: Timothy Markman, MDTaking people

About the trial

What the trial wants to find out

Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.

The group in the trial

  • Stellate ganglion blockTreatment being tested

    All subjects will undergo stellate ganglion block during their VT ablation procedure

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
Plain-language title
Stellate ganglion block and its effects on the heart in ventricular tachycardiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
21 November 2025